Rohto Pharmaceutical Co Ltd
TSE:4527
Rohto Pharmaceutical Co Ltd
TSE:4527
Price:
2 753 JPY
-1.92%
Market Closed
Updated:
May 25, 2024
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
11.2
Current
14.8
Median
10.4
Industry
Lower
than median
Higher
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=11.2
Enterprise Value
/
544B
EBITDA
48.7B
All Countries
| Market Cap | EV/EBITDA | ||||
|---|---|---|---|---|---|
| JP |
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
628.1B JPY | 11.2 | |
| FR |
|
L'Oreal SA
PAR:OR
|
239.2B EUR | 25.6 | |
| UK |
|
Unilever PLC
LSE:ULVR
|
107.4B GBP | 198.1 | |
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.6T INR | 37.1 | |
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
45.2B USD | 23.4 | |
| UK |
|
HALEON PLC
LSE:HLN
|
29.8B GBP | 12.8 | |
| DE |
|
Beiersdorf AG
XETRA:BEI
|
33.2B EUR | 17.1 | |
| JP |
|
Kao Corp
TSE:4452
|
3.2T JPY | 16.6 | |
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.3T INR | 42.9 | |
| JP |
|
Shiseido Co Ltd
TSE:4911
|
2T JPY | 21.7 | |
| IN |
|
Dabur India Ltd
NSE:DABUR
|
989B INR | 40.5 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
9.9
2-Years Forward
EV/EBITDA
9
3-Years Forward
EV/EBITDA
8
You don't have any saved screeners yet
